STOCK TITAN

[Form 4] Salesforce, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Craig Conway, a director of Salesforce, Inc. (CRM), reported the acquisition of 274 shares of common stock on 08/22/2025. The Form 4 shows the shares resulted from the vesting of 274 restricted stock units (RSUs) that convert one-for-one to common stock and carried a $0 purchase price. The reporting person held 8,338 shares of common stock following the transaction. The filing was signed by an attorney-in-fact on 08/25/2025 and lists the standard RSU vesting schedule showing quarterly vesting dates including 02/22/2025 through 11/22/2025.

Craig Conway, membro del consiglio di Salesforce, Inc. (CRM), ha comunicato l'acquisto di 274 azioni ordinarie in data 22/08/2025. Il Modulo 4 indica che le azioni derivano dal vesting di 274 unità azionarie vincolate (RSU), convertite uno a uno in azioni ordinarie e con prezzo di acquisto pari a $0. Dopo l'operazione la persona segnalante deteneva 8.338 azioni ordinarie. Il documento è stato sottoscritto da un rappresentante autorizzato il 25/08/2025 e riporta il consueto piano di maturazione delle RSU con tranche trimestrali comprese tra il 22/02/2025 e il 22/11/2025.

Craig Conway, director de Salesforce, Inc. (CRM), informó la adquisición de 274 acciones ordinarias el 22/08/2025. El Formulario 4 muestra que las acciones provinieron del vencimiento de 274 unidades restringidas de acciones (RSU) que se convierten una a una en acciones ordinarias y tuvieron un precio de compra de $0. Tras la operación, la persona informante poseía 8.338 acciones ordinarias. La presentación fue firmada por un apoderado el 25/08/2025 y detalla el calendario habitual de consolidación de las RSU con vencimientos trimestrales desde el 22/02/2025 hasta el 22/11/2025.

Craig Conway, Salesforce, Inc.(CRM) 이사, 2025-08-22에 보통주 274주 취득을 보고했습니다. Form 4에는 해당 주식이 1대1로 보통주로 전환되며 매입가가 $0인 제한주식단위(RSU) 274주의 베스팅으로 발생했다고 기재되어 있습니다. 거래 후 보고자는 보통주 8,338주를 보유하고 있었습니다. 해당 서류는 2025-08-25에 대리인이 서명했으며, 2025-02-22부터 2025-11-22까지의 분기별 베스팅 날짜를 포함한 표준 RSU 베스팅 일정이 기재되어 있습니다.

Craig Conway, administrateur de Salesforce, Inc. (CRM), a déclaré l'acquisition de 274 actions ordinaires le 22/08/2025. Le formulaire 4 indique que ces actions résultent de la levée de 274 unités d'actions restreintes (RSU), converties une pour une en actions ordinaires et assorties d'un prix d'achat de 0 $. Après la transaction, la personne déclarante détenait 8 338 actions ordinaires. Le dépôt a été signé par un mandataire le 25/08/2025 et présente le calendrier standard de vesting des RSU avec des dates trimestrielles allant du 22/02/2025 au 22/11/2025.

Craig Conway, Direktor von Salesforce, Inc. (CRM), meldete am 22.08.2025 den Erwerb von 274 Stammaktien. Im Formular 4 heißt es, dass die Aktien aus der Vesting-Zahlung von 274 Restricted Stock Units (RSUs) stammen, die im Verhältnis 1:1 in Stammaktien umgewandelt wurden und einen Kaufpreis von $0 hatten. Nach der Transaktion hielt die meldepflichtige Person 8.338 Stammaktien. Die Einreichung wurde am 25.08.2025 von einem Bevollmächtigten unterzeichnet und enthält den üblichen RSU-Vestingplan mit vierteljährlichen Vesting-Terminen von 22.02.2025 bis 22.11.2025.

Positive
  • Insider acquisition disclosed transparently with transaction date, amount, and post-transaction holdings clearly stated
  • RSUs converted one-for-one to common stock at $0, reflecting routine equity compensation vesting
Negative
  • None.

Insights

TL;DR: Director received 274 shares from RSU vesting; modest insider accumulation with no cash outlay.

The Form 4 documents a routine vesting event where 274 RSUs converted to common stock at no cost to the reporting person. The post-transaction beneficial ownership is 8,338 shares, which is a small, clearly disclosed insider change and does not indicate any market-moving purchase or sale. This is a standard compensation-derived issuance rather than an open-market trade.

TL;DR: Disclosure is complete and follows standard Form 4 requirements for RSU vesting.

The filing provides required details including transaction date, number of shares acquired, resulting beneficial ownership, and the RSU vesting schedule. Signature by an attorney-in-fact is provided. There are no indications of amendments, plans, or sale transactions; the disclosure aligns with routine director compensation reporting obligations.

Craig Conway, membro del consiglio di Salesforce, Inc. (CRM), ha comunicato l'acquisto di 274 azioni ordinarie in data 22/08/2025. Il Modulo 4 indica che le azioni derivano dal vesting di 274 unità azionarie vincolate (RSU), convertite uno a uno in azioni ordinarie e con prezzo di acquisto pari a $0. Dopo l'operazione la persona segnalante deteneva 8.338 azioni ordinarie. Il documento è stato sottoscritto da un rappresentante autorizzato il 25/08/2025 e riporta il consueto piano di maturazione delle RSU con tranche trimestrali comprese tra il 22/02/2025 e il 22/11/2025.

Craig Conway, director de Salesforce, Inc. (CRM), informó la adquisición de 274 acciones ordinarias el 22/08/2025. El Formulario 4 muestra que las acciones provinieron del vencimiento de 274 unidades restringidas de acciones (RSU) que se convierten una a una en acciones ordinarias y tuvieron un precio de compra de $0. Tras la operación, la persona informante poseía 8.338 acciones ordinarias. La presentación fue firmada por un apoderado el 25/08/2025 y detalla el calendario habitual de consolidación de las RSU con vencimientos trimestrales desde el 22/02/2025 hasta el 22/11/2025.

Craig Conway, Salesforce, Inc.(CRM) 이사, 2025-08-22에 보통주 274주 취득을 보고했습니다. Form 4에는 해당 주식이 1대1로 보통주로 전환되며 매입가가 $0인 제한주식단위(RSU) 274주의 베스팅으로 발생했다고 기재되어 있습니다. 거래 후 보고자는 보통주 8,338주를 보유하고 있었습니다. 해당 서류는 2025-08-25에 대리인이 서명했으며, 2025-02-22부터 2025-11-22까지의 분기별 베스팅 날짜를 포함한 표준 RSU 베스팅 일정이 기재되어 있습니다.

Craig Conway, administrateur de Salesforce, Inc. (CRM), a déclaré l'acquisition de 274 actions ordinaires le 22/08/2025. Le formulaire 4 indique que ces actions résultent de la levée de 274 unités d'actions restreintes (RSU), converties une pour une en actions ordinaires et assorties d'un prix d'achat de 0 $. Après la transaction, la personne déclarante détenait 8 338 actions ordinaires. Le dépôt a été signé par un mandataire le 25/08/2025 et présente le calendrier standard de vesting des RSU avec des dates trimestrielles allant du 22/02/2025 au 22/11/2025.

Craig Conway, Direktor von Salesforce, Inc. (CRM), meldete am 22.08.2025 den Erwerb von 274 Stammaktien. Im Formular 4 heißt es, dass die Aktien aus der Vesting-Zahlung von 274 Restricted Stock Units (RSUs) stammen, die im Verhältnis 1:1 in Stammaktien umgewandelt wurden und einen Kaufpreis von $0 hatten. Nach der Transaktion hielt die meldepflichtige Person 8.338 Stammaktien. Die Einreichung wurde am 25.08.2025 von einem Bevollmächtigten unterzeichnet und enthält den üblichen RSU-Vestingplan mit vierteljährlichen Vesting-Terminen von 22.02.2025 bis 22.11.2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Conway Craig

(Last) (First) (Middle)
415 MISSION STREET
3RD FLOOR

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/22/2025 M 274 A $0 8,338 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 08/22/2025 M 274 02/22/2025(2) 11/22/2025 Common Stock 274 $0 274 D
Explanation of Responses:
1. Restricted Stock Units convert to shares of common stock on a one-for-one basis.
2. These restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Sarah Dale, Attorney-in-Fact for Craig Conway 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Craig Conway report on the Form 4 for Salesforce (CRM)?

Craig Conway reported acquiring 274 shares of Salesforce common stock on 08/22/2025 due to RSU vesting.

How many shares did the reporting person own after the transaction?

8,338 shares of common stock were beneficially owned following the reported transaction.

What was the price paid for the acquired shares on the Form 4?

$0; the shares resulted from RSUs that convert one-for-one to common stock.

When did the reported RSUs vest?

Vesting dates listed include 02/22/2025, 05/22/2025, 08/22/2025, and 11/22/2025 with 25% vesting on each date.

Was the Form 4 signed and dated?

Yes. The form shows a signature by Sarah Dale, Attorney-in-Fact for Craig Conway, dated 08/25/2025.
Salesforce Com Inc

NYSE:CRM

CRM Rankings

CRM Latest News

CRM Latest SEC Filings

CRM Stock Data

233.02B
931.27M
2.58%
82.87%
1.43%
Software - Application
Services-prepackaged Software
Link
United States
SAN FRANCISCO